191 related articles for article (PubMed ID: 3783079)
1. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
[TBL] [Abstract][Full Text] [Related]
2. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin.
Akerlund M; Carlsson AM; Melin P; Trojnar J
Acta Obstet Gynecol Scand; 1985; 64(6):499-504. PubMed ID: 4061066
[TBL] [Abstract][Full Text] [Related]
3. Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist.
Hauksson A; Akerlund M; Melin P
Br J Obstet Gynaecol; 1988 Sep; 95(9):898-904. PubMed ID: 3191063
[TBL] [Abstract][Full Text] [Related]
4. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.
Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M
Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081
[TBL] [Abstract][Full Text] [Related]
5. Effects of vasopressin on the human non-pregnant uterus: studies with analogues of different vasopressor potencies.
Melin P; Trojnar J; Carlsson AM; Bengtsson B; Akerlund M; Robinson I
Eur J Pharmacol; 1988 Mar; 148(1):93-9. PubMed ID: 3383999
[TBL] [Abstract][Full Text] [Related]
6. Contractile effect of oxytocin and 1-deamino-1-carba-2-tyrosine (0-methyl)-oxytocin in myometrial tissue from non-pregnant and term pregnant women.
Norström A; Andersson A; Vilhardt H
Acta Endocrinol (Copenh); 1990 May; 122(5):566-8. PubMed ID: 2353554
[TBL] [Abstract][Full Text] [Related]
7. Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women.
Akerlund M; Hauksson A; Lundin S; Melin P; Trojnar J
Br J Obstet Gynaecol; 1986 Jan; 93(1):22-7. PubMed ID: 3942702
[TBL] [Abstract][Full Text] [Related]
8. Lysine vasopressin-induced increases in porcine myometrial contractility and intracellular Ca2+ concentrations of myometrial cells: involvement of oxytocin receptors.
Yu H; Zhuge R; Hsu WH
Biol Reprod; 1995 Mar; 52(3):584-590. PubMed ID: 7756452
[TBL] [Abstract][Full Text] [Related]
9. Effects of the non-peptide inhibitor OPC-21268 on oxytocin and vasopressin stimulation of rat and human myometrium.
Atke A; Vilhardt H; Hauzerova L; Barth T; Andersen LF
Eur J Pharmacol; 1995 Jul; 281(1):63-8. PubMed ID: 8566118
[TBL] [Abstract][Full Text] [Related]
10. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
11. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation.
Nathanielsz PW; Honnebier MB; Mecenas C; Jenkins SL; Holland ML; Demarest K
Biol Reprod; 1997 Aug; 57(2):320-4. PubMed ID: 9241045
[TBL] [Abstract][Full Text] [Related]
12. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
[TBL] [Abstract][Full Text] [Related]
13. Enhanced selectivity of oxytocin antagonists containing sarcosine in position 7.
Pavo I; Slaninova J; Klein U; Fahrenholz F
J Med Chem; 1994 Jan; 37(2):255-9. PubMed ID: 7507528
[TBL] [Abstract][Full Text] [Related]
14. 2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists.
Lammek B; Bankowski K; Misicka A; Manning M; Seto J; Sawyer WH
J Med Chem; 1989 Jan; 32(1):244-7. PubMed ID: 2909737
[TBL] [Abstract][Full Text] [Related]
15. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women.
Pierzynski P; Lemancewicz A; Reinheimer T; Akerlund M; Laudanski T
J Soc Gynecol Investig; 2004 Sep; 11(6):384-7. PubMed ID: 15350251
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity.
Melin P; Vilhardt H; Lindeberg G; Larsson LE; Akerlund M
J Endocrinol; 1981 Feb; 88(2):173-80. PubMed ID: 7193709
[TBL] [Abstract][Full Text] [Related]
18. Hydroxy analogues of oxytocin and of lysine-vasopressin.
Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban.
Manning M; Miteva K; Pancheva S; Stoev S; Wo NC; Chan WY
Int J Pept Protein Res; 1995; 46(3-4):244-52. PubMed ID: 8537178
[TBL] [Abstract][Full Text] [Related]
20. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
Manning M; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]